We reported our experience with high-risk, non-metastatic second portion duodenal GISTs in patients who underwent 1-month neoadjuvant cycles with imatinib therapy followed by pancreas-preserving surgery and 12-month of adjuvant chemotherapic regimen including imatinib. This study was conducted to evaluate the short and long-term results.
Pancreas preserving surgery for duodenal gastrointestinal stromal tumor removal / Crocetti, Daniele; Sapienza, Paolo; Cisano, Claudio; Tarallo, Mariarita; Polistena, Andrea; Venturini, Luigi; Pedulla', Giuseppe; DE TOMA, Giorgio. - In: MINERVA CHIRURGICA. - ISSN 0026-4733. - STAMPA. - 71:5(2016), pp. 281-285.
Pancreas preserving surgery for duodenal gastrointestinal stromal tumor removal
CROCETTI, DANIELE
;SAPIENZA, Paolo;CISANO, CLAUDIO;TARALLO, MARIARITA;POLISTENA, ANDREA;VENTURINI, LUIGI;PEDULLA', GIUSEPPE;DE TOMA, Giorgio
2016
Abstract
We reported our experience with high-risk, non-metastatic second portion duodenal GISTs in patients who underwent 1-month neoadjuvant cycles with imatinib therapy followed by pancreas-preserving surgery and 12-month of adjuvant chemotherapic regimen including imatinib. This study was conducted to evaluate the short and long-term results.| File | Dimensione | Formato | |
|---|---|---|---|
|
Crocetti_Pancreas-preserving-GIST_2016.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
580.82 kB
Formato
Adobe PDF
|
580.82 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
